Abstract

Protective effects of estrogen (E2) on traumatic brain injury (TBI) have been determined. In this study, the hepatoprotective effects of E2 after TBI through its receptors and oxidative stress regulation have been evaluated. Diffuse TBI induced by the Marmarou method in male rats. G15, PHTPP, MPP, and ICI182?780 as selective antagonists of E2 were injected before TBI. The results indicated that TBI induces a significant increase in liver enzymes Alkaline phosphatase (ALP), Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), Glutamyl transferase (GGT), and oxidants levels Malondialdehyde (MDA), Nitric oxide (NO) and decreases in antioxidant biomarkers Glutathione peroxidase (GPx) and Superoxide dismutase (SOD) in the brain and liver, and plasma. We also found that E2 significantly preserved levels of these biomarkers and enzymatic activity. All antagonists inhibited the effects of E2 on increasing SOD and GPx. Also, the effects of E2 on brain MDA levels were inhibited by all antagonists, but in the liver, only ICI + G15 + E2 + TBI group was affected. The impacts of E2 on brain and liver and plasma NO levels were inhibited by all antagonists. The current findings demonstrated that E2 probably improved liver injury after TBI by modulating oxidative stress. Also, both classic (ER?, ER?) and non-classic G protein-coupled estrogen receptor (GPER) receptors are affected in the protective effects of E2.